Rationale for using recombinant human erythropoietin to treat the anemia of prematurity.
Phibbs
R H
RH
Department of Pediatrics and Cardiovascular Research Institute, University of California, San Francisco.
Shannon
K
K
Mentzer
W C
WC
D000740:Anemia / Q000097:blood / Q000188:drug therapy* / Q000628:therapy; D001803:Blood Transfusion; D004921:Erythropoietin / Q000627:therapeutic use*; D006400:Hematocrit; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature
D004921:Erythropoietin